The official U.S. response to classic psychedelics has been primarily a defense of existing normality. The response was aroused, for example, by the drop out kicker in Tim Learys famous motto (turn on, tune in, drop out). It was shaped by perceived links to social disarray caused by claims of equality from blacks, women, people dismissed as shiftless, and foreigners who resented intervention (such as in Vietnam).
My own introduction to the drug issue came from a college student when I was a teaching assistant at Stanford in a course on personality theory. It was back in the late 1960s. I was told this pill is really great, this student reported being assured at a frat party. Swallow it and get ready for a really good time. He didn't even ask what the pill was said to be, much less seek data on what it actually contained. He just swallowed. LSD was soon made illegal. (As we will see below, this was far from an ideal set and setting.)
When U.S. research on psychedelics was allowed to resume, decades later, it was largely for projects that explored medicinal uses, which aim to restore a person toyou guessed itnormality. Has most of society been afraid not only of party drugs, but also of the experience of awe? Awe is regarded as okay for the occasional mystic, who may even be elevated to sainthood (for example, Francis of Assisi, after whom the current Pope chose to be named), but it arouses suspicion when people talk to birds. Thats weird.
Nobody wants vast criminal syndicates, users do not want the risk of impure drugs (with dangerous molecules sometimes being sold as Ecstasy), nobody wants their children thrown in prison for smoking pot while good burghers drive their cars to a bar to get plastered, nobody wants to pay higher taxes to keep non-violent young people locked up, and researchers do not want prohibitions on research about amazing substances, even if they were not widely used. But anything in defense of normality.
The big question is whether were ever going to find a way to integrate awe into lives that are otherwise normal, to tolerate a regime under which people can, if they want, suspend ordinary reality in a safe and beneficial way. At least since 1954, when Aldous Huxleys Doors of Perception gave us that brilliant writers account of his trip on a classic psychedelic, explorers have tried to bridge the gap between their direct experience and the views of the majority who werent burdened by personal encounters with awe but who, with the help of the media, knew what they believed.
Huxleys spirit was put in a religious context by Huston Smith, who spoke of cleansing those Blakeian doors.
More recently, people who feel that a therapeutic trip has been one of the most important experiences of their lifetime or have found mega benefits in micro-dosing have adopted various rhetorical strategies to try to communicate their discovery. Im reminded of this attempt, which has now continued for a half century or so, by two recent books, The Psychedelic Renaissance (2012) by Ben Sessa, and A Really Good Day (2017) by Ayelet Waldman.
An English physician and researcher, Sessa adopts the strategy of identifying with his profession and searching for ways that classic psychedelics (and MDMA) can help psychiatrists reduce unnecessary suffering. At the same time, he wonders aloud why, after scorning hippies, he has adopted many of their values and insights. Then he returns to the sobriety of his status in society, his caseload, and research based on double-blind evidence.
Waldman adopts a different strategy. Professionally, she is a writer. She is also a mother of four. She suffers from depression and anxiety. She had heard that taking a tenth of a normal dose of LSD might help. She followed a protocol described by Jim Fadiman, who began researching psychedelics as a graduate student when LSD-25 was still legal. This accounts for Waldmans subtitle: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life.
Assured of a supply for a month of three-day cycles, Waldman supposedly wonders whether even a micro-dose will kill her or, if not, drive her crazy, with ghastly flashbacks. Despite having been a volunteer for the Drug Policy Alliance, which works against the war on drugs, and in spite of teaching a law school course in the area, Waldman says she started her personal experiment with fear-based stories widely held in our society, inculcated by the misinformation our government has propagated for decades. She then educates her readers with the quite different facts.
So these are the first two rhetorical strategies: identify with your audience (I thought so, too, but boy, was I mistaken) or identify with a valued profession (Im a doctor, I just want to find medicines that work).
One way to make drugs almost acceptable is to present them as potential medicines, under the control of a highly regarded corps of professionals. Can they treat PTSD, as in the studies of MDMA as an adjunct to therapy, studies conducted by the Mithoefers? Can they ease end-of-life fear, as in the project run by Charles Grob? Can they deal with addiction to alcohol and other legal drugs open to abuse?
Another strategy is to argue that, under the Constitution, liberty includes the right to alter, at least temporarily, ones own consciousness: you may not have the freedom to encourage or guide others, but an individual in our society does retain the power to decide what to put in his or her own body, especially if its been shown to be safer than substances sold and imbibed freely.
We have Jim Fadiman to thank not only for Ayelet Waldmans experiment but also for other effects of his own book, The Psychedelic Explorers Guide: Safe, Therapeutic and Sacred Journeys (2011). In contrast to my student reporting on unknown drugs handed around at a frat party, Fadiman describes how to do it right. Experienced people advise: (a) ingest a psychedelic only if you are mentally balanced, (b) get pure substances, (c) take a correct dose, (d) form a positive intention for the trip (and then be willing to let go of it), (e) find and stay in a welcoming non-clinical setting, (f) have an experienced and non-intrusive guide, (g) lie down or find a comfortable chair, (h) listen to music instead of operating machinery or communicating with people outside the room. Of course, prohibition makes it difficult to get pure substances, and current law would make any guide an accessory.
Another rhetorical strategy was inherent in the 1960s project on psychedelics and creativity led by Professor Willis Harman. This project gave a classic psychedelic to professionals who were working with resistant challenges in their fields. It discovered benefits before the project was cut off when the government decided to make LSD illegal. That was in 1968 (the same year Martin Luther King, Jr., was shot, Bobby Kennedy won the California primary and was then assassinated, and Richard Nixon nabbed the Presidency).
If creativity is not enough to win approval, how about a hypothesis about evolution of the species, that it was psilocybin that helped convert primates into archaic humans? Along with many other speculations in the course of his career, Terence McKenna explored this possibility around 1992. What was his motive? If we could import into straight society, almost as a Trojan horse, the idea that these psychedelic compounds and plants are the catalyst that called forth humanness out of animal nature, if we could entertain this as a possibility, he said, it would alter societys efforts to control and eradicate these substances.
In contrast to proposing bold but unprovable theories, recent researchers looked at neurological data, gathered in large part by methods not yet available when classic psychedelics became widespread in the U.S. For example, Robin Carhart-Harris at Imperial College in London used magnetic resonance imagining to map effects in the brain.
Data about spiritual experience was reported in research led by Professor Roland Griffiths at Johns Hopkins, as expressed in the classic paper, Psilocybin occasioned mystical-type experiences The investigators focused not on an illness that was to be alleviated but rather on an enhancement of ordinary life.
To summarize the rhetorical strategies cited here:
There are other rhetorical strategies, but these are enough to illustrate the persistence and ingenuity of people who are still seeking, after a half century of prohibition, to bridge the gap between firm beliefs of the general public and data developed, against official resistance, by research both here and abroad.
When fear is aroused, as in the war on terror, good public policy is swept aside and we tend not to look at facts.
In the case of psychedelics, what will work? We are encouraged to be patient, as was Martin Luther King, Jr., by white colleagues at the time of the Montgomery demonstrations. In response, King asked whether the time since the Civil War was long enough to wait.
The prohibition against psychedelics has lasted about half a century. Critics of the fear-response decry the losses: the healing that has been lost, the abuse of liberty, the loss of research, of creativity, of experiences of awe.
One of the U.S. organizations that has worked persistently and ingeniously during most of this period of prohibition has been the Multidisciplinary Association for Psychedelic Studies (MAPS), founded by Rick Doblin, a graduate of Harvards Kennedy School. MAPS has held conferences on psychedelic science, sponsored research here and abroad, published a newsletter, and tried to educate the political establishment.
Other leading organizations include the Heffter Research Institute, which gathered key academics in this field, Amanda Feildings Beckley Foundation in the U.K., Bob Jesses Council for Spiritual Practices, the archives at Purdue University (Psychoactive Substances Research Collection), and the Vaults of Erowid.
On the model of cannabis, perhaps it would be helpful to establish medical uses, then move on to what is called recreational use, a term that refers to all uses not controlled solely by physicians but freely available to the public. The term recreational is prejudicial like the term drugs, which fails to distinguish between classic psychedelics and addictive or otherwise harmful drugs, such as heroin.
For example, there is nothing recreational about the experience of awe or of wonder. The term trivializes what can happen. Drugs are taken not only to get high or cure a health condition, but also to take a holiday from the confines of ordinary reality, as in studying a textbook, buying a house, raising children, serving as a professional, and so forth. What if, instead of an ill-conceived and unworkable prohibition, we focused our ingenuity on making the opportunity for good trips part of a normal life?
One pioneer who sketched this possibility was Gordon Wasson, a U.S. banker who made a famous trip to a tribal area of Mexico and experienced a psilocybin mushroom ceremony with a local shaman, and wrote about it in Life magazine (in1957, a few years after Huxleys book). What was his first reaction after the mushroom took effect? I felt awestruck.
Later he co-authored a book, The Road to Eleusis (1978), working with Albert Hofmann, the Swiss chemist who synthesized and then, in 1943, discovered the mental effects of LSD, and with a professor of classics named Carl Ruck. They proposed that the ancient ceremony at Eleusis included a psychedelic. (No one knows for sure because the participants were sworn to secrecy.) The point is, the ritual was not counter-cultural but part of the culture, not for everybody, but not considered a challenge to the dominant way of life.
Perhaps our culture will accept the value of psychedelics through demonstrations of their usefulness in alleviating suffering, through medical applications. But it was observers such as Wasson who understood that their most extraordinary value was experiencing awe and that this opportunity could become part of a normal life.
Follow this link:
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019
- A Magic Mushroom Test Case, and the Man Behind It - OZY - November 30th, 2019
- The Two Black Women Helping To Reclaim & Encourage Natural Psychedelics Use In Oakland - Okayplayer - November 2nd, 2019
- Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain - Decrypt - November 2nd, 2019
- On writing: What illuminates a story? - Big Think - November 2nd, 2019
- The future of psychedelic science - Varsity - October 20th, 2019
- Psychedelic Drugs: Researchers experimenting with active agent in magic mushrooms to treat addiction, depression and anxiety - 60 Minutes - CBS News - October 17th, 2019
- Investors hope psychedelics are the new cannabis. Are they high? - The Economist - October 17th, 2019
- Mind Trip: Psychedelics Fighting Depression, Anxiety, Addiction - The National Herald - October 17th, 2019
- Devon Welsh on Growing a Mustache, Psychedelics, and Other Complicated Things - Interview - October 17th, 2019
- Roland Griffiths: 5 Fast Facts You Need to Know - Heavy.com - October 17th, 2019
- How Mushrooms Became Magic - The Atlantic - August 25th, 2017
- Using Mushrooms and LSD to Enhance Creativity - How to Use ... - August 20th, 2017
- LSD - Psychedelics - August 16th, 2017
- This Philosopher Thinks Psychedelic Drugs Lead to the Truth of Experience - Big Think - August 16th, 2017
- Can Psychedelics Treat Bipolar Disorder? - August 13th, 2017
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz - August 13th, 2017
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk - August 8th, 2017
- Daniel Greig, Canadian Drug Policy, Responsibilities, and Psychedelics - The Good Men Project (blog) - August 6th, 2017
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine - August 5th, 2017
- Gonzo Nieto, Drug Policy, Medical and Psychological Effects - The Good Men Project (blog) - August 3rd, 2017
- For children, it's beyond psychedelics - The Hans India - The Hans India - August 1st, 2017
- Modern psychedelic science is reviving lost research and finding new cures - The Plaid Zebra (blog) - August 1st, 2017
- Expanding consciousness - 48 Hills - August 1st, 2017
- What Has Awe Done for Me Lately? - HuffPost - July 31st, 2017
- New book about psychedelics and weird human experiences - Boing Boing - July 26th, 2017
- Reasons to Consider Trying Psychedelics - FoxWeekly - July 25th, 2017
- Psychedelic Shine takes a trip to the skies in Boulder - Boulder Daily Camera - July 22nd, 2017
- Psychedelic drugs could tackle depression in a way that antidepressants can't - INSIDER - July 22nd, 2017
- Do You Take Drugs at Festivals? This Initiative is Working on Keeping You Safe - PoliticalCritique.org - July 20th, 2017
- Should We Reclassify Marijuana as a Hallucinogen? - Big Think - July 20th, 2017
- Countdown To (Legalized) Ecstasy! Rick Doblin, MAPS, & the Psychedelic Renaissance [Podcast] - Reason (blog) - July 20th, 2017
- Can Psychedelics Be Therapy? Allow Research to Find Out - New York Times - July 18th, 2017
- Psychiatrists Say Cannabis Medicine Has Psychedelic Properties - The Marijuana Times - July 15th, 2017
- Are psychedelics the new medical marijuana? - WTSP 10 News - July 13th, 2017
- Alameda author's new book examines psychedelic drugs' medical use - East Bay Times - July 12th, 2017
- Do Psychedelic Drugs Cause the 'Prophetic Effect'? - Breaking Israel ... - Breaking Israel News - July 11th, 2017
- Shrooms Could Be Legalized Sooner Than You Think - VICE - July 11th, 2017
- Parliament George and the Psychedelics? Mayor gets playful lesson on hipness - The Telegraph (blog) - July 8th, 2017
- About Us | Trusted News Source for Psychedelic Research ... - July 7th, 2017
- My grandfather was a death row doctor. He tested psychedelic drugs on Texas inmates. - Texas Tribune - July 5th, 2017
- Psychedelics Could Help Asia's Mental Health Care, But Stigma Remains Roadblock - TheFix.com - July 4th, 2017
- Is LSD the new coffee? - FactorDaily - July 4th, 2017
- Tune in, Turn on, Stay in School - Study Breaks - July 2nd, 2017
- The brain on DMT: mapping the psychedelic drug's effects - Wired.co.uk - July 2nd, 2017
- Cannabist Show: He's psychedelic comedian Shane Mauss - The Cannabist - July 1st, 2017
- The war on drugs is back. Will psychedelic drug research survive? - The Verge - June 29th, 2017
- Psychedelics and Virtual Reality Make a Trendy but Illegal Therapy - Inverse - June 27th, 2017
- Director Ana Lily Amirpour on Cannibalism, Psychedelics, and 'Horrifying' Racism Allegations - Jezebel - June 24th, 2017